- $1.87bn
- $1.84bn
- $309.91m
Annual income statement for BH Macro, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 53.9 | 375 | 189 | 231 | 310 |
| Cost of Revenue | |||||
| Gross Profit | 36.7 | 287 | 159 | 186 | 277 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 28.9 | 114 | 123 | 139 | 159 |
| Operating Profit | 25.1 | 261 | 65.7 | 92 | 151 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 12 | 112 | 66.5 | 58.2 | 151 |
| Net Income After Taxes | 12 | 112 | 66.5 | 58.2 | 151 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 12 | 112 | 66.5 | 58.2 | 151 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 12 | 112 | 66.5 | 58.2 | 151 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.058 | 0.358 | 0.174 | 0.142 | 0.423 |